📰 Tissue Engineering News
Page 41 - Tissue Engineering News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tissue Engineering. Real-time updates on events, politics, business and more.
November 23, 2021
For decades, the study of tissue-engineered skeletal muscle has been driven by a clinical need to treat neuromuscular diseases and volumetric muscle loss. The in vitro fabrication of muscle offers the opportunity to test drug-and cell-based therapies, to study disease processes, and to perhaps, one day, serve as a muscle graft for reconstructive surgery. This study developed a biofabrication technique to engineer muscle for research and clinical applications. A bioprinting protocol was establish...
November 23, 2021
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to...
November 5, 2021
Congratulations to our Duke faculty who have been promoted or appointed to the rank of full professor! Promotion and appointment to full professor is the culmination of a rigorous review by academic peers and leaders.
November 5, 2021
Exipure Ingredients Reviews, Is It A 100% Natural & Safe Weight Loss Supplement
November 5, 2021
Exipure Ingredients Reviews, Is It A 100% Natural & Safe Weight Loss Supplement
November 2, 2021
Exipure Tropical Loophole Reviews, Important Information No One Will Tell You
November 2, 2021
Exipure Tropical Loophole Reviews, Important Information No One Will Tell You
October 29, 2021
NEW YORK, Oct. 29, 2021 /PRNewswire/ -- With the presence of a large pool of participants, the global cell culture media market is displaying a highly competitive business landscape, finds a
October 28, 2021
Experiments in mice show prolonged normal blood sugar levels after a single autograft procedure using their own engineered muscle cells.
October 21, 2021
Biotech Executive Brings Extensive Experience Developing Advanced Therapies and Regenerative MedicinesLEXINGTON, Mass. and AMSTERDAM, Oct. 21, 2021N.V. (NASDAQ: QURE), a leading gene therapy company advancing